Home | Aclaris Therapeutics Inc.
Aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. Learn about our pipeline.
Stats
Alexa Rank: 4077664
Popular in Country:
Country Alexa Rank:
language: en-US
Response Time: 1.394552
SSL: Enable
Status: up
Code To Txt Ratio
Word Count 282
Links
ratio 5.9480410643201
SSL Details
SSL Issuer:
Issuer: R3
Valid From: 2022-06-08 13:20:11
Expiration Date: 2022-09-06 13:20:10
SSL Organization:
Signature ddc37626c62e9c22684be732393446e76d3590f9
Algorithm: RSA-SHA256
Found 76 Top Alternative to Aclaristx.com
Rubiustx.com
Home - Rubius Therapeutics
Rubius Therapeutics | Red Cell Therapeutics™️ | Home Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines. Learn More.
130.211.162.83
United States
InValid
SSL
G1therapeutics.com
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
Bioxceltherapeutics.com
BioXcel Therapeutics Inc – BioXcel Therapeutics Inc
Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches. Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and...
Onconova.com
Onconova Therapeutics, Inc. - A Biopharmaceutical Company
Onconova Therapeutics, Inc. is focused on discovering and developing novel small molecule drug candidates to treat cancer.
Capricor.com
Capricor Therapeutics
Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and prevention of Diseases
Frequencytx.com
FX 322 | Regenerative Medicine | Hearing Restoration| Frequency Therapeutics
Frequency Therapeutics is actively working to transform the treatment of hearing loss. Learn more about our approach to degenerative diseases.
Akebia.com
Home - Akebia Therapeutics
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Rigel.com
Rigel Pharmaceuticals, Inc. (RIGL)
Investors News & Events Contact Us Home Who We Are Company Overview Management Team Board of Directors Partners Pipeline Pipeline Clinical Trials Investigator Sponsored Research Expanded Access Policy Proprietary Programs Warm AIHA COVID-19 IRAK1/4 RIPK1 Partnered Programs BerGenBio Daiichi-Sankyo Grifols Kissei Lilly Medison Knight Products Join Our Team Life at...
Sperotherapeutics.com
Developing MDR Bacterial Infection Treatments | Spero Therapeutics
Leading Product Candidates Spero Therapeutics is developing a portfolio of novel product candidates with the potential for meaningful patient impact and significant commercial applications. As a leader in the infectious disease field, we are highly committed to advancing new therapies for patients with serious infections. Our candidates are designed to...
Cidara.com
Leading the Science of Protection - Cidara Therapeutics
Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases. Antifungal: REZAFUNGIN A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections Cloudbreak® Drug-Fc Conjugates Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit...
Celldex.com
Celldex Therapeutics
Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.
Allogene.com
Home - Allogene
THE NEXT REVOLUTION IN CELL THERAPY Allogene is developing allogeneic chimeric antigen receptor T cell (AlloCAR T™) products to find the next immunologic breakthrough in cancer. That’s how we’re leading today, creating tomorrow. LEARN ABOUT AlloCAR T™ THE NEXT REVOLUTION IN CELL THERAPY Allogene is developing allogeneic chimeric antigen receptor T...
Herontx.com
Acute Care and Oncology Care Solutions | Heron Therapeutics
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.
Poseida.com
Home - Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical needs.
Serestherapeutics.com
Establishing a Better Microbiome for Better Health - Seres Therapeutics
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Discover our progress.
Acrs.org
Home - ACRS
COVID-19 ADVISORY: ACRS is offering limited essential services at ACRS offices to clients by appointment only and arranged by case managers via phone. These essential services support clients with acute, critical needs and will be determined by staff who can translate in different languages. All clients need to schedule an...
Marinuspharma.com
Home - Marinus Pharmaceuticals : Marinus Pharmaceuticals
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.
Amicusrx.com
Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
Tgtherapeutics.com
TG Therapeutics
ABOUT US Our Story Message From Our CEO Leadership Team Board Members Guiding Principles Join Us OUR SCIENCE Our Approach Our Focus MZL/FL CLL MS Collaborate With Us Meet with TG Medical OUR PRODUCTS OUR PIPELINE Overview Umbralisib Ublituximab TG-1501 TG-1701 TG 1801 OUR PUBLICATIONS OUR TRIALS Trial Information Expanded...
Sorrentotherapeutics.com
Home - Sorrento Therapeutics
Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19
Regulusrx.com
Regulus Therapeutics
Delivering life-changing therapeutics to patients with orphan kidney diseases About Us We are laser-focused on our mission: to improve the lives of patients and their families. Clinical Trials Our pipeline programs target kidney diseases of high unmet need, including ADPKD. Programs We are targeting the underlying biology of these diseases...
Voyagertherapeutics.com
Voyager Therapeutics
Unlocking breakthroughs in AAV gene therapy and developing best-in-class treatments for CNS and other diseases.
Halozyme.com
Home | Halozyme
Halozyme has completed its acquisition of Antares Pharma, Inc., creating a leading drug delivery business. View details here. Inspiring New Inspiring New As of May 24, 2022, Halozyme completed its acquisition of Antares Pharma Inc., creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’...
Acorda.com
Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Fatetherapeutics.com
Home - Fate Therapeutics
Privacy Overview This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you...
Formatherapeutics.com
Clinical-Stage Biopharmaceutical Company - Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Mirati.com
Mirati Therapeutics, Inc. | Relentless Focus on Innovation | Targeted Oncology
At Mirati, we are relentlessly focused on developing best-in-class targeted therapies to meaningfully impact the lives of patients with cancer.
Folliclethought.com
Follicle Thought – Hair Growth Treatment News – Hair Loss Cure News – Treatments For Baldness
76 Comments Updated on June 15, 2022 Exosomes Therapies For Hair Loss Several new companies are developing exosome therapies to treat hair loss. Unlike previous iterations of exosomes treatments, these therapies will undergo clinical trials within the FDA approval process. Exosomes And Hair Growth Around two years ago, exosomes became...
Technologies Used by aclaristx.com
Dns Records of aclaristx.com
A Record: 35.208.108.143AAAA Record:
CNAME Record:
NS Record: ns11.domaincontrol.com ns12.domaincontrol.com
SOA Record: dns.jomax.net
MX Record: us-smtp-inbound-1.mimecast.com us-smtp-inbound-2.mimecast.com
SRV Record:
TXT Record: knowbe4-site-verification=c101cafe518f806e96d341102f9142e0 v=spf1 mx include:_netblocks.mimecast.com ~all have-i-been-pwned-verification=4cdf37ed0bbbcd6c855d3ed44797f636 0ed1fe018ad4f97fc6f7874f99a53aeb48e3d79f60 v=spf1 ip4:50.236.115.98 include:aclaristx-com.mail.protection.outlook.com ~all
DNSKEY Record:
CAA Record:
Whois Detail of aclaristx.com
Domain Name: ACLARISTX.COMRegistry Domain ID: 1733744277_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: https://www.godaddy.com
Updated Date: 2021-07-14T13:13:56Z
Creation Date: 2012-07-13T22:32:30Z
Registrar Registration Expiration Date: 2022-07-13T22:32:30Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.4806242505
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Registry Registrant ID: Not Available From Registry
Registrant Name: Registration Private
Registrant Organization: Domains By Proxy, LLC
Registrant Street: DomainsByProxy.com
Registrant Street: 2155 E Warner Rd
Registrant City: Tempe
Registrant State/Province: Arizona
Registrant Postal Code: 85284
Registrant Country: US
Registrant Phone: +1.4806242599
Registrant Phone Ext:
Registrant Fax: +1.4806242598
Registrant Fax Ext:
Registrant Email: Select Contact Domain Holder link at https://www.godaddy.com/whois/results.aspx?domain=ACLARISTX.COM
Registry Admin ID: Not Available From Registry
Admin Name: Registration Private
Admin Organization: Domains By Proxy, LLC
Admin Street: DomainsByProxy.com
Admin Street: 2155 E Warner Rd
Admin City: Tempe
Admin State/Province: Arizona
Admin Postal Code: 85284
Admin Country: US
Admin Phone: +1.4806242599
Admin Phone Ext:
Admin Fax: +1.4806242598
Admin Fax Ext:
Admin Email: Select Contact Domain Holder link at https://www.godaddy.com/whois/results.aspx?domain=ACLARISTX.COM
Registry Tech ID: Not Available From Registry
Tech Name: Registration Private
Tech Organization: Domains By Proxy, LLC
Tech Street: DomainsByProxy.com
Tech Street: 2155 E Warner Rd
Tech City: Tempe
Tech State/Province: Arizona
Tech Postal Code: 85284
Tech Country: US
Tech Phone: +1.4806242599
Tech Phone Ext:
Tech Fax: +1.4806242598
Tech Fax Ext:
Tech Email: Select Contact Domain Holder link at https://www.godaddy.com/whois/results.aspx?domain=ACLARISTX.COM
Name Server: NS11.DOMAINCONTROL.COM
Name Server: NS12.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2022-06-16T02:27:13Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
TERMS OF USE: The data contained in this registrar's Whois database, while believed by the
registrar to be reliable, is provided "as is" with no guarantee or warranties regarding its
accuracy. This information is provided for the sole purpose of assisting you in obtaining
information about domain name registration records. Any use of this data for any other purpose
is expressly forbidden without the prior written permission of this registrar. By submitting
an inquiry, you agree to these terms and limitations of warranty. In particular, you agree not
to use this data to allow, enable, or otherwise support the dissemination or collection of this
data, in part or in its entirety, for any purpose, such as transmission by e-mail, telephone,
postal mail, facsimile or other means of mass unsolicited, commercial advertising or solicitations
of any kind, including spam. You further agree not to use this data to enable high volume, automated
or robotic electronic processes designed to collect or compile this data for any purpose, including
mining this data for your own personal or commercial purposes. Failure to comply with these terms
may result in termination of access to the Whois database. These terms may be subject to modification
at any time without notice.